Terbium-161 might be superior to lutetium-177 for oligometastases - Authors' reply.

Saved in:
Bibliographic Details
Title: Terbium-161 might be superior to lutetium-177 for oligometastases - Authors' reply.
Authors: Privé BM; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, Netherlands; Department of Radiation Oncology, Erasmus MC, Rotterdam, Netherlands; Department of Medical Imaging, Radboudumc, Radboud Institute for Health Sciences, 6500 HB Nijmegen, Netherlands. Electronic address: bastiaan.prive@radboudumc.nl., Noordzij W; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Peters S; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, Netherlands., Timmermans BJR; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, Netherlands., Vrachimis A; Department of Nuclear Medicine, German Oncology Centre, Limassol, Cyprus., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, Netherlands; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Amsterdam, Netherlands., Nagarajah J; Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, Netherlands; Roentgeninstitut Duesseldorf, Duesseldorf, Germany.
Source: The Lancet. Oncology [Lancet Oncol] 2026 Jul; Vol. 27 (7), pp. e320.
Publication Type: Letter
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(26)00294-9